Compare Traphaco JSC with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 19.49%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 98.15
3
Poor long term growth as Operating profit has grown by an annual rate 4.75% of over the last 5 years
4
Flat results in Sep 25
5
With ROE of 15.63%, it has a expensive valuation with a 1.91 Price to Book Value
6
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
VND 3,287,028 Million (Small Cap)
12.00
NA
5.04%
-0.37
15.81%
2.12
Revenue and Profits:
Net Sales:
624,074 Million
(Quarterly Results - Mar 2026)
Net Profit:
60,653 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.12%
0%
5.12%
6 Months
2.56%
0%
2.56%
1 Year
-2.2%
0%
-2.2%
2 Years
-13.04%
0%
-13.04%
3 Years
-14.26%
0%
-14.26%
4 Years
10.34%
0%
10.34%
5 Years
37.69%
0%
37.69%
Traphaco JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.13%
EBIT Growth (5y)
4.75%
EBIT to Interest (avg)
98.15
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
1.51
Tax Ratio
20.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
40.79%
ROE (avg)
19.49%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
1.97
EV to EBIT
7.24
EV to EBITDA
5.66
EV to Capital Employed
2.50
EV to Sales
0.95
PEG Ratio
0.57
Dividend Yield
5.64%
ROCE (Latest)
34.46%
ROE (Latest)
16.55%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
624,074.20
749,330.40
-16.72%
Operating Profit (PBDIT) excl Other Income
115,933.60
115,423.00
0.44%
Interest
2,291.00
1,410.60
62.41%
Exceptional Items
0.00
0.00
Consolidate Net Profit
60,653.40
64,699.20
-6.25%
Operating Profit Margin (Excl OI)
148.90%
122.40%
2.65%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -16.72% vs 10.89% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -6.25% vs 2.23% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,584,146.60
2,347,221.10
10.09%
Operating Profit (PBDIT) excl Other Income
417,535.00
397,863.80
4.94%
Interest
6,962.10
5,544.70
25.56%
Exceptional Items
0.00
0.00
Consolidate Net Profit
245,498.80
225,171.70
9.03%
Operating Profit Margin (Excl OI)
125.30%
130.60%
-0.53%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 10.09% vs 2.09% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 9.03% vs -10.45% in Dec 2024
About Traphaco JSC 
Traphaco JSC
Pharmaceuticals & Biotechnology
Traphaco Joint Stock Company is a Vietnam-based pharmaceutical manufacturer. The Company manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. It is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry. Other activities of the Company include manufacturing and trading beer, wine and soft drinks (excluding bar business). As of December 31, 2012, the Company had three subsidiaries operating in the similar industry. As of the same date, it had 14 branches.
Company Coordinates 
Company Details
So 75 Yen Ninh, Quan Ba Dinh , HANOI None : None
Registrar Details






